Skip to content

NexGen Metabolomics:

The new standard in health, wellness, and longevity.

Beyond genotype to phenotype.

It's not what you might be (genetics) but what you really are (phenotype).

Phenotype = genetics + environment.

With over 15 years of experience in cancer and metabolism our founders have identified metabolic signatures that extend from cancer to diabetes, cardiovascular disease to neurodegenerative disease and numerous health conditions.

Using our METASYNCTM Analysis, we analyze plasma metabolites and generate unique biochemical fingerprints for:

  • Nutritional assessment & metabolic individuality

  • Performance optimization

  • Longevity & anti-aging strategies

  • Recovery and metabolic rebalancing during cancer therapy

Learn About Our TestingRead Patient Stories

Themed Subpanels

Clinically Relevant Insights by Functional Domain

  • Brain & Neurotransmitter Function
  • Energy Production & Mitochondrial Function
  • Essential Nutrient Profile
  • Immune & Inflammatory Function
  • Liver Function & Detoxification
  • Muscle Health & Sarcopenia
  • Metabolic Stress & Toxic Load
  • Longevity & Immunosenescence Profile
How to Order
Report Sample Page2

The METASYNC™ Analysis applies targeted Mass Spectrometry (LC-MS/MS and FIA-MS/MS) profiling, to provide actionable measures of the principal pathways of nutrition, mitochondrial function, detoxification, immune response, and aging.

We check these and more...

Metabolic syndrome and insulin resistance

Cardiovascular and neurodegenerative disease

Sleep and mood disorders

Immune dysfunction and autoimmunity

Aging and longevity biology

In the US alone, the numbers speak for themselves. (source: CDC)

40.5%
of all Americans will get cancer
129M
Have at least one major chronic condition
40%
Have at least two or more chronic diseases
Logo-HIPAA_Protecting-Your-Health-Information

QUALITY & PRIVACY

All laboratory testing is done in a CLIA-certified laboratory in southern California and your patient rights are respected under HIPAA.

From CDC.gov, "The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations include federal standards applicable to all U.S. facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease."

HIPAA Privacy Rights

Contact Us at Metabolomycs

Reach out to us about how our Next Generation Metabolomics testing can help you improve the lives of your patients.

Let's talk!